Volume 5, Issue 2, Page 8 (February 2010)
9 of 37
PREVIEW
FULL TEXT
FULL-TEXT PDF (238 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The weight-loss drug sibutramine is now contraindicated in people with a history of cardiovascular disease, the Food and Drug Administration announced Jan. 21.
PII: S1558-0164(10)70052-3
doi:10.1016/S1558-0164(10)70052-3
© 2010 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW